274 related articles for article (PubMed ID: 34625516)
1. Why are US military personnel prescribed transdermal fentanyl patches?
Murray H; Gregoriou AN; Lepore A; Booth GJ; Goldman AH; Allen ML; Balazs GC
BMJ Mil Health; 2023 Aug; 169(4):335-339. PubMed ID: 34625516
[TBL] [Abstract][Full Text] [Related]
2. Assessment of Potentially Inappropriate Prescribing of Opioid Analgesics Requiring Prior Opioid Tolerance.
Jeffery MM; Chaisson CE; Hane C; Rumanes L; Tucker J; Hang L; McCoy R; Chen CL; Bicket MC; Hooten WM; Larochelle M; Becker WC; Kornegay C; Racoosin JA; Sanghavi D
JAMA Netw Open; 2020 Apr; 3(4):e202875. PubMed ID: 32293684
[TBL] [Abstract][Full Text] [Related]
3. Oral opioid prescribing to active duty US military personnel: a cross-sectional population.
Junge JM; Murray H; Goldman AH; Booth GJ; Balazs GC
Reg Anesth Pain Med; 2024 May; 49(5):339-345. PubMed ID: 37507224
[TBL] [Abstract][Full Text] [Related]
4. Use of transdermal fentanyl without prior opioid stabilization in patients with cancer pain.
Tawfik MO; Bryuzgin V; Kourteva G;
Curr Med Res Opin; 2004 Mar; 20(3):259-67. PubMed ID: 15025835
[TBL] [Abstract][Full Text] [Related]
5. Inappropriate Fentanyl Prescribing Among Nursing Home Residents in the United States.
Fain KM; Castillo-Salgado C; Dore DD; Segal JB; Zullo AR; Alexander GC
J Am Med Dir Assoc; 2017 Feb; 18(2):138-144. PubMed ID: 27720662
[TBL] [Abstract][Full Text] [Related]
6. Transdermal fentanyl for the management of cancer pain: a survey of 1005 patients.
Radbruch L; Sabatowski R; Petzke F; Brunsch-Radbruch A; Grond S; Lehmann KA
Palliat Med; 2001 Jul; 15(4):309-21. PubMed ID: 12054148
[TBL] [Abstract][Full Text] [Related]
7. Utilisation of transdermal fentanyl in Germany from 2004 to 2006.
Garbe E; Jobski K; Schmid U
Pharmacoepidemiol Drug Saf; 2012 Feb; 21(2):191-8. PubMed ID: 21681850
[TBL] [Abstract][Full Text] [Related]
8. Automated profile review for transdermal fentanyl to verify opioid tolerance in the military health system.
Devine JW; Trice S; Nwokeji E; Yarger S; Anekwe TM; Davies W; Lawrence J
Mil Med; 2013 Nov; 178(11):1241-4. PubMed ID: 24183773
[TBL] [Abstract][Full Text] [Related]
9. Transdermal fentanyl in opioid-naive cancer pain patients: an open trial using transdermal fentanyl for the treatment of chronic cancer pain in opioid-naive patients and a group using codeine.
Vielvoye-Kerkmeer AP; Mattern C; Uitendaal MP
J Pain Symptom Manage; 2000 Mar; 19(3):185-92. PubMed ID: 10760623
[TBL] [Abstract][Full Text] [Related]
10. Transdermal fentanyl. A review of its pharmacological properties and therapeutic efficacy in pain control.
Jeal W; Benfield P
Drugs; 1997 Jan; 53(1):109-38. PubMed ID: 9010652
[TBL] [Abstract][Full Text] [Related]
11. Safety of fentanyl initiation according to past opioid exposure among patients newly prescribed fentanyl patches.
Friesen KJ; Woelk C; Bugden S
CMAJ; 2016 Jun; 188(9):648-653. PubMed ID: 27044480
[TBL] [Abstract][Full Text] [Related]
12. Opioid tolerance and urine drug testing among initiates of extended-release or long-acting opioids in Food and Drug Administration's Sentinel System.
Larochelle MR; Cocoros NM; Popovic J; Dee EC; Kornegay C; Ju J; Racoosin JA
J Opioid Manag; 2017; 13(5):315-327. PubMed ID: 29199397
[TBL] [Abstract][Full Text] [Related]
13. A population-based study of transdermal fentanyl initiation in Australian clinical practice.
Gisev N; Pearson SA; Larance B; Larney S; Blanch B; Degenhardt L
Eur J Clin Pharmacol; 2019 Mar; 75(3):401-408. PubMed ID: 30392109
[TBL] [Abstract][Full Text] [Related]
14. Opioid Use Patterns Among Active Duty Service Members and Civilians: 2006-2014.
Kazanis W; Pugh MJ; Tami C; Maddry JK; Bebarta VS; Finley EP; McGeary DD; Carnahan DH; Potter JS
Mil Med; 2018 Mar; 183(3-4):e157-e164. PubMed ID: 29514335
[TBL] [Abstract][Full Text] [Related]
15. Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control.
Muijsers RB; Wagstaff AJ
Drugs; 2001; 61(15):2289-307. PubMed ID: 11772140
[TBL] [Abstract][Full Text] [Related]
16. Transdermal matrix fentanyl membrane patch (matrifen): in severe cancer-related chronic pain.
Hair PI; Keating GM; McKeage K
Drugs; 2008; 68(14):2001-9. PubMed ID: 18778121
[TBL] [Abstract][Full Text] [Related]
17. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
18. Fentanyl nasal spray (Lazanda) for pain.
Med Lett Drugs Ther; 2011 Dec; 53(1379-1380):99-100. PubMed ID: 22173454
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal symptoms under opioid therapy: a prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphine.
Wirz S; Wittmann M; Schenk M; Schroeck A; Schaefer N; Mueller M; Standop J; Kloecker N; Nadstawek J
Eur J Pain; 2009 Aug; 13(7):737-43. PubMed ID: 18977159
[TBL] [Abstract][Full Text] [Related]
20. Initiation of Transdermal Fentanyl Among US Commercially Insured Patients Between 2007 and 2015.
Costantino RC; Gressler LE; Onukwugha E; McPherson ML; Fudin J; Villalonga-Olives E; Slejko JF
Pain Med; 2020 Oct; 21(10):2229-2236. PubMed ID: 32377671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
